JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn’t plan to stop there, exec says

JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn’t plan to stop there, exec says
esagonowsky
Thu, 01/13/2022 – 08:39